Ellie Collins
Earlier this month, six Oxford PharmaGenesis editors attended sessions of the online Chartered Institute of Editing and Proofreading (CIEP) conference. A range of topics were presented, including use of macros in editing, style sheets, digital marketing and inclusive language. Some of the presentations provided essential ‘nuts and bolts’ information, while others took a more in-depth […]
Read MoreThe Oxford PharmaGenesis Patient Engagement Team was lucky enough to attend the World Orphan Drug Congress Europe earlier in November. The virtual conference provided invaluable insights into hot topics and current issues for rare diseases. Of much interest to our team were patient centricity, initiatives working with patient groups/advocates and, specifically, discussions around access and […]
Read More
Oxford PharmaGenesis is proud to support CISCRP in a new educational initiative to increase awareness and understanding of clinical research among minority urban communities. We have collaborated with CISCRP to sponsor an advertisement that highlights the key importance of diversity among participants in clinical studies in order to discover treatments that are effective for everyone. […]
Read MoreThe annual World Pharma Pricing Market Access & Evidence congress was held on 23–25 September 2020 for the first time in a virtual environment, and was attended by members of our Value Demonstration Practice.
Read More
Mental health for all. Greater investment – greater access. Everyone, everywhere. Oxford PharmaGenesis is committed to ensuring good mental health and well-being for all of its employees, offering access to support services, training and other valuable resources. We also host a team of trained Mental Health First Aiders (MHFAs) who serve as a point of […]
Read More
Oxford PharmaGenesis was delighted to attend the recent eyeforpharma Patient Summit 2020 earlier this month. As part of the ‘new normal’, the meeting this year was virtual, and content was available on demand. This allowed multiple members of the Patient Engagement Team to attend and gain insights on the latest in the patient engagement field. […]
Read More
Alan Thomas is a patient advocate for rare diseases, and ataxia in particular. He is known as the ‘rare disease warrior’ and, as a patient with a life-limiting rare disease, he can convey the patient engagement message from his point of view on all issues regarding the wellbeing of patients.
Read More
After finishing my undergraduate degree in biomedical sciences, I was eager to harness the skills I had developed and transfer them to a new environment. This led me to apply for an internship at Oxford PharmaGenesis.
Read MoreThroughout the COVID-19 pandemic, Oxford PharmaGenesis has been in the fortunate position of being able to continue to recruit HealthScience experts for a variety of roles across our global locations. We asked a few of our new colleagues to share their experiences of joining us remotely.
Read MoreThroughout the COVID-19 pandemic, our colleagues have volunteered their time in many different and inspiring ways. Read more about the experiences of two of our colleagues.
Read More